Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $59.97 Analyst target: $97.80 Upside: 63.08%
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. The company is headquartered in South Plainfield, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.